Newsfeeds Archive - Page 2 of 7

1 minute read

Legal
News

Delaware Court Denies CareDx’s Motion For Summary Judgment On Two Natera Patents; Achieves Key Objective For Trial Set To Begin On Jan. 22nd

December 11, 1:53 PM

Natera successfully achieves key objective for trial set to begin on Jan. 22ndNatera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA testing, today announced that the United States District Court for the District

CDNA

2 minute read

Movers

12 Health Care Stocks Moving In Thursday’s Pre-Market Session

By Benzinga Insights

November 9, 9:06 AM

Gainers Intelligent Bio Solutions (NASDAQ:INBS) shares increased by 72.0% to $0.39 during Thursday’s pre-market session. The market value…

AKLI

1 minute read

Earnings

CareDx: Q3 Earnings Insights

By Benzinga Insights

November 8, 5:35 PM

CareDx (NASDAQ:CDNA) reported its Q3 earnings results on Wednesday, November 8, 2023 at 04:05 PM. Here’s what investors…

CDNA

24 minute read

Earnings

Earnings Scheduled For November 8, 2023

By Benzinga Insights

November 8, 5:21 AM

Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its third quarter.

AADI

1 minute read

Earnings

Earnings Outlook For CareDx

By Benzinga Insights

November 7, 1:02 PM

CareDx (NASDAQ:CDNA) is set to give its latest quarterly earnings report on Wednesday, 2023-11-08. Here’s what investors need…

CDNA

2 minute read

Movers

12 Health Care Stocks Moving In Thursday’s Pre-Market Session

By Benzinga Insights

November 2, 9:05 AM

Gainers Panbela Therapeutics (NASDAQ:PBLA) shares rose 62.0% to $1.29 during Thursday’s pre-market session. The company’s market cap stands…

ACXP

2 minute read

Movers

12 Health Care Stocks Moving In Wednesday’s After-Market Session

By Benzinga Insights

November 1, 5:31 PM

Gainers Phathom Pharmaceuticals (NASDAQ:PHAT) stock moved upwards by 11.1% to $10.68 during Wednesday’s after-market session. The market value…

ALRN

2 minute read

CareDx Announces CEO Transition, Dr. Reginald Seeto To Step Down; Board Establishes Office Of The CEO, Conducts Search For Successor; Raises 2023 Revenue Guidance To $274M-$278M Vs $255.42M Est.

By Benzinga Newsdesk

November 1, 5:12 PM

Board Establishes Office of the CEO, Conducts Search for SuccessorRaises 2023 Revenue GuidanceCareDx, Inc. (NASDAQ:CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of

CDNA